| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/17/2008 | CN101268098A Liquid formulations of pegylated growth hormone |
| 09/17/2008 | CN101267843A Artificial platelets |
| 09/17/2008 | CN101267842A Use of conjugates of doxorubicin with lactosaminated albumin |
| 09/17/2008 | CN101267841A Process for preparing maytansinoid antibody conjugates |
| 09/17/2008 | CN101267840A Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 09/17/2008 | CN101267839A Chitosan-silicon dioxide coprecipitate and use as excipient in solid dosage forms |
| 09/17/2008 | CN101267806A Sustained release of antifectives |
| 09/17/2008 | CN101267805A Systems and methods for manufacturing liposomes |
| 09/17/2008 | CN101265312A Amphipathic three block copolymer and its preparation method and application |
| 09/17/2008 | CN101265311A Method for preparing PVP-PEG-PLA shell-crosslinked nano micelle |
| 09/17/2008 | CN101265304A Bionic chitosan derivatives, preparation method thereof and lipoid plastid preparation containing the same |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264331A New purpose of Chinese medicine almond |
| 09/17/2008 | CN101264330A Macromolecule material drug carrier system for targeted therapy and preparation and application thereof |
| 09/17/2008 | CN101264327A Magnetic target carrier system |
| 09/17/2008 | CN101264326A Alzheimer's disease treatment method |
| 09/17/2008 | CN101264320A Oxygen-carrying blood substitute preparations |
| 09/17/2008 | CN101264319A Preparation of exenatide freeze-drying preparation |
| 09/17/2008 | CN101264299A Medicine for treating chronic hepatitis B and preparation thereof |
| 09/17/2008 | CN101264280A Chinese medicine emplastrum dosage form and externally-applied emplastrum preparations prepared from the dosage form |
| 09/17/2008 | CN101264276A Oral preparation of í«chaihu dayuaní» decoction |
| 09/17/2008 | CN101264265A Medicaments for treating common cold and cough |
| 09/17/2008 | CN101264262A Medicine for treating tuberculosis and preparation thereof |
| 09/17/2008 | CN101264196A Externally-applied medicinal composition for treating surgical wound and preparation of ointment thereof |
| 09/17/2008 | CN101264195A Compound dragon's blood gel preparations and extraction and preparation technique |
| 09/17/2008 | CN101264193A Chinese medicine for treating breast bump and mammary hyperplasia and preparation thereof |
| 09/17/2008 | CN101264177A Tablet forming candy with refreshing, pharynx-clearing and throat-smoothing action |
| 09/17/2008 | CN101264154A Preparation of Chinese medicine oral preparation |
| 09/17/2008 | CN101264137A 'Baidai Shenfang' oral preparation and preparation thereof |
| 09/17/2008 | CN101264130A Film coating agent for treating skin ulcer |
| 09/17/2008 | CN101264129A Sugar-free heart-supplementing dracocephali moldavica granula |
| 09/17/2008 | CN101264125A Natural medicine oral preparation for treating dropsy |
| 09/17/2008 | CN101264124A Natural medicine colonic capsules for treating hemorrhoidal disease |
| 09/17/2008 | CN101264123A Natural medicine dropping pills for treating hemorrhoidal disease |
| 09/17/2008 | CN101264108A Preparation of concentrated Chinese medicine |
| 09/17/2008 | CN101264087A Medicinal composition containing cefpodoxime proxetil cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264086A Medicinal composition containing cefixime cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264085A Medicinal composition containing cefdinir cyclodextrin inclusion compound and preparation thereof |
| 09/17/2008 | CN101264079A Oxymatrine nano preparations for liver cell targeting injection and preparation thereof |
| 09/17/2008 | CN101264078A Jiabing sustained-release film and preparation thereof |
| 09/17/2008 | CN101264067A Florfenicol capsule for silkworm |
| 09/17/2008 | CN101264065A Racecadotril dropping pill and preparation thereof |
| 09/17/2008 | CN101264064A Vinpocetine freeze-dried powder for injection and preparation thereof |
| 09/17/2008 | CN101264063A Stable tetrodotoxin preparations under room temperature for injection |
| 09/17/2008 | CN101264062A Production technology for preparing freeze-drying genetic engineering bacterium competence cell and protective agent formula |
| 09/17/2008 | CN101264058A Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof |
| 09/17/2008 | CN101264057A PH-sensitive long circulating liposomes composition and preparation thereof |
| 09/17/2008 | CN101264056A Epirubicin hydrochloride liposome and preparation thereof |
| 09/17/2008 | CN101264055A Cimetidine emulsion for treating esophagitis and gastropathy and preparation thereof |
| 09/17/2008 | CN101264054A Rifamycin sodium injection and preparation thereof |
| 09/17/2008 | CN101264051A Modified release pharmaceutical formulation |
| 09/17/2008 | CN100418581C Method for preparation of polyester magnetic composite microsphere capable of being biodegraded |
| 09/17/2008 | CN100418580C Heat resistant freeze drying protectant for chicken Newcastle disease live vaccine and its prepn and application |
| 09/17/2008 | CN100418579C Preparation absorbed through skin |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/17/2008 | CN100418527C Improved pharmaceutical formulations |
| 09/17/2008 | CN100418520C Apoferritin ¿Cplatinum anticancer drug composition and preparation method thereof |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 09/16/2008 | US7425582 Stabilized dispersions comprising excipient surface-modified organic nanoparticles and medicament particles |
| 09/16/2008 | US7425581 Temperature sensitive polymers |
| 09/16/2008 | US7425541 Therapy of tumors; prodrugs that display a high specificity of action, a reduced toxicity, and an improved stability in blood |
| 09/16/2008 | US7425535 Therapeutic pore-forming peptides |
| 09/16/2008 | US7425341 granulating a mixture of compressible water soluble carbohydrates, compressible water insoluble fillers, ondansetron and solvents, drying, mixing with disintegrants, lubricants, surfactants, flavors, sweeteners and colorants, and compressing to form tablets, that form suspensions, slurries or dispersions |
| 09/16/2008 | US7425340 a mixture of antispasmodic agents and carriers comprising urea compounds for intensifying permeability through the skin or mucous membranes, used for treating incontinence; side effect reduction |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | US7425218 Nitric oxide-releasing medical devices |
| 09/16/2008 | CA2623858A1 Stabilized chlorine dioxide and hypochlorous acid in a liquid biocide |
| 09/16/2008 | CA2447519C Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 09/16/2008 | CA2414349C Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 09/16/2008 | CA2403949C Transdermal therapeutic system for the delivery of lerisetron |
| 09/16/2008 | CA2384448C Method of treatment of seborrheic dermatitis |
| 09/16/2008 | CA2378503C Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation |
| 09/16/2008 | CA2346062C Coated medicament forms with controlled active substance release |
| 09/16/2008 | CA2339290C Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 09/16/2008 | CA2322315C Fast disintegrating tablets |
| 09/16/2008 | CA2292730C Stabilized antibody formulation |
| 09/16/2008 | CA2277757C Modified tumor necrosis factor |
| 09/16/2008 | CA2273017C Local administration device for solid or semi-solid formulations, time-release formulations for parenteral administration and their method of preparation |
| 09/16/2008 | CA2215378C Diltiazem controlled release formulation |
| 09/16/2008 | CA2195633C Blood-pool imaging compositions use and method |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/16/2008 | CA2166062C The use of non-ionic surfactants in stable topical retinoid compositions |
| 09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/16/2008 | CA2110730C Sustained-release preparation |
| 09/12/2008 | WO2008109740A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 09/12/2008 | WO2008109230A2 Therapeutic composition with enhanced endothelium targeting |
| 09/12/2008 | WO2008109163A1 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 09/12/2008 | WO2008109068A2 A conjugate of insulin and vitamin b12 for oral delivery |
| 09/12/2008 | WO2008109031A2 Liposome carriers for in vivo delivery of fullerenes |
| 09/12/2008 | WO2008109005A2 Use of anti-cd22 immunotoxins and protein-synthesis-inhibiting chemotherapeutic agents in treatment of b cell cancers |
| 09/12/2008 | WO2008108736A1 Particles for delivery of bioactive factors |
| 09/12/2008 | WO2008108505A1 Novel nuclear translocation peptide |
| 09/12/2008 | WO2008108424A1 Device for the transdermal administration of bisoprolol |
| 09/12/2008 | WO2008108411A1 Polyrotaxanes and material having polyrotaxane, crosslinked polyrotaxanes and material having the crosslinked polyrotaxane, and processes for producing these |
| 09/12/2008 | WO2008108286A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |